Design and Validation of a Questionnaire to Evaluate Healthcare Providers’ Practices of Pharmacovigilance Article Swipe
Amina Hani Saleem
,
Harith Al-Qazaz
,
Omer Qutaiba B Allela
,
Fahad Saleem
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.33899/iraqij.p.2025.159387.1142
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.33899/iraqij.p.2025.159387.1142
Background: Pharmacovigilance is an important tool that ensures the safe use of medications during their entire life cycle. Healthcare providers are the main contributors to pharmacovigilance activities, and reporting adverse drug reactions is a core obligation of their clinical practice. The aim was to evaluate the validity and reliability of an adapted and translated version of the knowledge, attitude and practice (KAP) questionnaire specified on pharmacovigilance among healthcare providers. Methods: An observational cross-sectional survey was performed among 30 healthcare providers (n=30) to obtain their demographic data. This pilot study was conducted in Mosul city hospitals in November 2024. The other data were collected using the translated KAP questionnaire which consists of 14 questions related to knowledge, 6 questions related to attitude, 5 questions related to practice, and 1 question related to barriers to adverse drug reaction reporting. Descriptive statistics were employed. Reliability was tested using Cronbach’s alpha. Results: Ten healthcare providers of each profession were included in the study (pharmacist, physician, nurse). The mean knowledge score was 8.03 ± 2.10 out of 14, while the mean attitude was 26.36 ± 2.25 out of 30, and the practice mean was 2.2667 ± 1.94 out of 5. The internal consistency was found to be good (Cronbach’s alpha =0.729, 0.722, and 0.722 for knowledge, attitude, and practice, respectively). Face-content validity was employed, and five specialists evaluated the validity of the questionnaire. Construct validity was also proven, where the total KAP scores were shown to be significantly higher among healthcare providers with a history of pharmacovigilance training. Conclusion: This study concluded that the translated KAP pharmacovigilance questionnaire is reliable and valid for evaluating the knowledge, attitude and practice among healthcare providers in Nineveh.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.33899/iraqij.p.2025.159387.1142
- OA Status
- diamond
- Cited By
- 1
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4411037242
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4411037242Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.33899/iraqij.p.2025.159387.1142Digital Object Identifier
- Title
-
Design and Validation of a Questionnaire to Evaluate Healthcare Providers’ Practices of PharmacovigilanceWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-06-04Full publication date if available
- Authors
-
Amina Hani Saleem, Harith Al-Qazaz, Omer Qutaiba B Allela, Fahad SaleemList of authors in order
- Landing page
-
https://doi.org/10.33899/iraqij.p.2025.159387.1142Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.33899/iraqij.p.2025.159387.1142Direct OA link when available
- Concepts
-
Pharmacovigilance, Health care, Business, Medicine, Medical education, Pharmacology, Adverse effect, Political science, LawTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1Per-year citation counts (last 5 years)
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4411037242 |
|---|---|
| doi | https://doi.org/10.33899/iraqij.p.2025.159387.1142 |
| ids.doi | https://doi.org/10.33899/iraqij.p.2025.159387.1142 |
| ids.openalex | https://openalex.org/W4411037242 |
| fwci | 3.43037969 |
| type | article |
| title | Design and Validation of a Questionnaire to Evaluate Healthcare Providers’ Practices of Pharmacovigilance |
| biblio.issue | 0 |
| biblio.volume | 0 |
| biblio.last_page | 0 |
| biblio.first_page | 0 |
| topics[0].id | https://openalex.org/T11943 |
| topics[0].field.id | https://openalex.org/fields/30 |
| topics[0].field.display_name | Pharmacology, Toxicology and Pharmaceutics |
| topics[0].score | 0.9936000108718872 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/3005 |
| topics[0].subfield.display_name | Toxicology |
| topics[0].display_name | Pharmacovigilance and Adverse Drug Reactions |
| topics[1].id | https://openalex.org/T11492 |
| topics[1].field.id | https://openalex.org/fields/33 |
| topics[1].field.display_name | Social Sciences |
| topics[1].score | 0.9847000241279602 |
| topics[1].domain.id | https://openalex.org/domains/2 |
| topics[1].domain.display_name | Social Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/3311 |
| topics[1].subfield.display_name | Safety Research |
| topics[1].display_name | Academic integrity and plagiarism |
| topics[2].id | https://openalex.org/T12878 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9144999980926514 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2739 |
| topics[2].subfield.display_name | Public Health, Environmental and Occupational Health |
| topics[2].display_name | Pharmaceutical Quality and Counterfeiting |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C57658597 |
| concepts[0].level | 3 |
| concepts[0].score | 0.9306685924530029 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1550789 |
| concepts[0].display_name | Pharmacovigilance |
| concepts[1].id | https://openalex.org/C160735492 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6292839050292969 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q31207 |
| concepts[1].display_name | Health care |
| concepts[2].id | https://openalex.org/C144133560 |
| concepts[2].level | 0 |
| concepts[2].score | 0.3860948085784912 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q4830453 |
| concepts[2].display_name | Business |
| concepts[3].id | https://openalex.org/C71924100 |
| concepts[3].level | 0 |
| concepts[3].score | 0.3423509895801544 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[3].display_name | Medicine |
| concepts[4].id | https://openalex.org/C509550671 |
| concepts[4].level | 1 |
| concepts[4].score | 0.32205814123153687 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q126945 |
| concepts[4].display_name | Medical education |
| concepts[5].id | https://openalex.org/C98274493 |
| concepts[5].level | 1 |
| concepts[5].score | 0.15852031111717224 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[5].display_name | Pharmacology |
| concepts[6].id | https://openalex.org/C197934379 |
| concepts[6].level | 2 |
| concepts[6].score | 0.15040767192840576 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q2047938 |
| concepts[6].display_name | Adverse effect |
| concepts[7].id | https://openalex.org/C17744445 |
| concepts[7].level | 0 |
| concepts[7].score | 0.12238535284996033 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q36442 |
| concepts[7].display_name | Political science |
| concepts[8].id | https://openalex.org/C199539241 |
| concepts[8].level | 1 |
| concepts[8].score | 0.0 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7748 |
| concepts[8].display_name | Law |
| keywords[0].id | https://openalex.org/keywords/pharmacovigilance |
| keywords[0].score | 0.9306685924530029 |
| keywords[0].display_name | Pharmacovigilance |
| keywords[1].id | https://openalex.org/keywords/health-care |
| keywords[1].score | 0.6292839050292969 |
| keywords[1].display_name | Health care |
| keywords[2].id | https://openalex.org/keywords/business |
| keywords[2].score | 0.3860948085784912 |
| keywords[2].display_name | Business |
| keywords[3].id | https://openalex.org/keywords/medicine |
| keywords[3].score | 0.3423509895801544 |
| keywords[3].display_name | Medicine |
| keywords[4].id | https://openalex.org/keywords/medical-education |
| keywords[4].score | 0.32205814123153687 |
| keywords[4].display_name | Medical education |
| keywords[5].id | https://openalex.org/keywords/pharmacology |
| keywords[5].score | 0.15852031111717224 |
| keywords[5].display_name | Pharmacology |
| keywords[6].id | https://openalex.org/keywords/adverse-effect |
| keywords[6].score | 0.15040767192840576 |
| keywords[6].display_name | Adverse effect |
| keywords[7].id | https://openalex.org/keywords/political-science |
| keywords[7].score | 0.12238535284996033 |
| keywords[7].display_name | Political science |
| language | en |
| locations[0].id | doi:10.33899/iraqij.p.2025.159387.1142 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210239752 |
| locations[0].source.issn | 1680-2594, 2664-2522 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1680-2594 |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Al-Mağallaẗ al-ʻirāqiyyaẗ li-l-ṣaydalaẗ |
| locations[0].source.host_organization | |
| locations[0].source.host_organization_name | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Iraqi Journal of Pharmacy |
| locations[0].landing_page_url | https://doi.org/10.33899/iraqij.p.2025.159387.1142 |
| locations[1].id | pmh:oai:doaj.org/article:b91d007416184e71a106cf26c71072c2 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306401280 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[1].source.host_organization | |
| locations[1].source.host_organization_name | |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | article |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | المجلة العراقية للصيدلة, Vol 22, Iss 3, Pp 116-122 (2025) |
| locations[1].landing_page_url | https://doaj.org/article/b91d007416184e71a106cf26c71072c2 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5108654765 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Amina Hani Saleem |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Amina Hani Saleem |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5017616821 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-5223-0065 |
| authorships[1].author.display_name | Harith Al-Qazaz |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Harith Al-Qazaz |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5108021164 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-6803-9794 |
| authorships[2].author.display_name | Omer Qutaiba B Allela |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Omer Allela |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5050455291 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-8100-8992 |
| authorships[3].author.display_name | Fahad Saleem |
| authorships[3].author_position | last |
| authorships[3].raw_author_name | Fahad Saleem |
| authorships[3].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.33899/iraqij.p.2025.159387.1142 |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Design and Validation of a Questionnaire to Evaluate Healthcare Providers’ Practices of Pharmacovigilance |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11943 |
| primary_topic.field.id | https://openalex.org/fields/30 |
| primary_topic.field.display_name | Pharmacology, Toxicology and Pharmaceutics |
| primary_topic.score | 0.9936000108718872 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/3005 |
| primary_topic.subfield.display_name | Toxicology |
| primary_topic.display_name | Pharmacovigilance and Adverse Drug Reactions |
| related_works | https://openalex.org/W4391375266, https://openalex.org/W2899084033, https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 2 |
| best_oa_location.id | doi:10.33899/iraqij.p.2025.159387.1142 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210239752 |
| best_oa_location.source.issn | 1680-2594, 2664-2522 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1680-2594 |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Al-Mağallaẗ al-ʻirāqiyyaẗ li-l-ṣaydalaẗ |
| best_oa_location.source.host_organization | |
| best_oa_location.source.host_organization_name | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Iraqi Journal of Pharmacy |
| best_oa_location.landing_page_url | https://doi.org/10.33899/iraqij.p.2025.159387.1142 |
| primary_location.id | doi:10.33899/iraqij.p.2025.159387.1142 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210239752 |
| primary_location.source.issn | 1680-2594, 2664-2522 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1680-2594 |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Al-Mağallaẗ al-ʻirāqiyyaẗ li-l-ṣaydalaẗ |
| primary_location.source.host_organization | |
| primary_location.source.host_organization_name | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Iraqi Journal of Pharmacy |
| primary_location.landing_page_url | https://doi.org/10.33899/iraqij.p.2025.159387.1142 |
| publication_date | 2025-06-04 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.1 | 126 |
| abstract_inverted_index.5 | 120 |
| abstract_inverted_index.6 | 115 |
| abstract_inverted_index.a | 33, 247 |
| abstract_inverted_index.14 | 110 |
| abstract_inverted_index.30 | 76 |
| abstract_inverted_index.5. | 193 |
| abstract_inverted_index.An | 69 |
| abstract_inverted_index.an | 3, 49 |
| abstract_inverted_index.be | 200, 240 |
| abstract_inverted_index.in | 90, 94, 155, 276 |
| abstract_inverted_index.is | 2, 32, 262 |
| abstract_inverted_index.of | 11, 36, 48, 54, 109, 150, 170, 181, 192, 224, 249 |
| abstract_inverted_index.on | 63 |
| abstract_inverted_index.to | 24, 42, 80, 113, 118, 123, 129, 131, 199, 239 |
| abstract_inverted_index.14, | 171 |
| abstract_inverted_index.30, | 182 |
| abstract_inverted_index.KAP | 105, 235, 259 |
| abstract_inverted_index.Ten | 147 |
| abstract_inverted_index.The | 97, 161, 194 |
| abstract_inverted_index.aim | 40 |
| abstract_inverted_index.and | 27, 46, 51, 58, 125, 183, 206, 211, 218, 264, 271 |
| abstract_inverted_index.are | 20 |
| abstract_inverted_index.for | 208, 266 |
| abstract_inverted_index.out | 169, 180, 191 |
| abstract_inverted_index.the | 8, 21, 44, 55, 103, 156, 173, 184, 222, 225, 233, 257, 268 |
| abstract_inverted_index.use | 10 |
| abstract_inverted_index.was | 41, 73, 88, 141, 165, 176, 187, 197, 216, 229 |
| abstract_inverted_index.1.94 | 190 |
| abstract_inverted_index.2.10 | 168 |
| abstract_inverted_index.2.25 | 179 |
| abstract_inverted_index.8.03 | 166 |
| abstract_inverted_index.This | 85, 253 |
| abstract_inverted_index.also | 230 |
| abstract_inverted_index.city | 92 |
| abstract_inverted_index.core | 34 |
| abstract_inverted_index.data | 99 |
| abstract_inverted_index.drug | 30, 133 |
| abstract_inverted_index.each | 151 |
| abstract_inverted_index.five | 219 |
| abstract_inverted_index.good | 201 |
| abstract_inverted_index.life | 16 |
| abstract_inverted_index.main | 22 |
| abstract_inverted_index.mean | 162, 174, 186 |
| abstract_inverted_index.safe | 9 |
| abstract_inverted_index.that | 6, 256 |
| abstract_inverted_index.tool | 5 |
| abstract_inverted_index.were | 100, 138, 153, 237 |
| abstract_inverted_index.with | 246 |
| abstract_inverted_index.(KAP) | 60 |
| abstract_inverted_index.0.722 | 207 |
| abstract_inverted_index.2024. | 96 |
| abstract_inverted_index.26.36 | 177 |
| abstract_inverted_index.Mosul | 91 |
| abstract_inverted_index.alpha | 203 |
| abstract_inverted_index.among | 65, 75, 243, 273 |
| abstract_inverted_index.data. | 84 |
| abstract_inverted_index.found | 198 |
| abstract_inverted_index.other | 98 |
| abstract_inverted_index.pilot | 86 |
| abstract_inverted_index.score | 164 |
| abstract_inverted_index.shown | 238 |
| abstract_inverted_index.study | 87, 157, 254 |
| abstract_inverted_index.their | 14, 37, 82 |
| abstract_inverted_index.total | 234 |
| abstract_inverted_index.using | 102, 143 |
| abstract_inverted_index.valid | 265 |
| abstract_inverted_index.where | 232 |
| abstract_inverted_index.which | 107 |
| abstract_inverted_index.while | 172 |
| abstract_inverted_index.(n=30) | 79 |
| abstract_inverted_index.0.722, | 205 |
| abstract_inverted_index.2.2667 | 188 |
| abstract_inverted_index.alpha. | 145 |
| abstract_inverted_index.cycle. | 17 |
| abstract_inverted_index.during | 13 |
| abstract_inverted_index.entire | 15 |
| abstract_inverted_index.higher | 242 |
| abstract_inverted_index.obtain | 81 |
| abstract_inverted_index.scores | 236 |
| abstract_inverted_index.survey | 72 |
| abstract_inverted_index.tested | 142 |
| abstract_inverted_index.=0.729, | 204 |
| abstract_inverted_index.adapted | 50 |
| abstract_inverted_index.adverse | 29, 132 |
| abstract_inverted_index.ensures | 7 |
| abstract_inverted_index.history | 248 |
| abstract_inverted_index.nurse). | 160 |
| abstract_inverted_index.proven, | 231 |
| abstract_inverted_index.related | 112, 117, 122, 128 |
| abstract_inverted_index.version | 53 |
| abstract_inverted_index.± | 167, 178, 189 |
| abstract_inverted_index.Methods: | 68 |
| abstract_inverted_index.Nineveh. | 277 |
| abstract_inverted_index.November | 95 |
| abstract_inverted_index.attitude | 57, 175, 270 |
| abstract_inverted_index.barriers | 130 |
| abstract_inverted_index.clinical | 38 |
| abstract_inverted_index.consists | 108 |
| abstract_inverted_index.evaluate | 43 |
| abstract_inverted_index.included | 154 |
| abstract_inverted_index.internal | 195 |
| abstract_inverted_index.practice | 59, 185, 272 |
| abstract_inverted_index.question | 127 |
| abstract_inverted_index.reaction | 134 |
| abstract_inverted_index.reliable | 263 |
| abstract_inverted_index.validity | 45, 215, 223, 228 |
| abstract_inverted_index.Construct | 227 |
| abstract_inverted_index.attitude, | 119, 210 |
| abstract_inverted_index.collected | 101 |
| abstract_inverted_index.concluded | 255 |
| abstract_inverted_index.conducted | 89 |
| abstract_inverted_index.employed, | 217 |
| abstract_inverted_index.employed. | 139 |
| abstract_inverted_index.evaluated | 221 |
| abstract_inverted_index.hospitals | 93 |
| abstract_inverted_index.important | 4 |
| abstract_inverted_index.knowledge | 163 |
| abstract_inverted_index.performed | 74 |
| abstract_inverted_index.practice, | 124, 212 |
| abstract_inverted_index.providers | 19, 78, 149, 245, 275 |
| abstract_inverted_index.questions | 111, 116, 121 |
| abstract_inverted_index.reactions | 31 |
| abstract_inverted_index.reporting | 28 |
| abstract_inverted_index.specified | 62 |
| abstract_inverted_index.training. | 251 |
| abstract_inverted_index.Healthcare | 18 |
| abstract_inverted_index.evaluating | 267 |
| abstract_inverted_index.healthcare | 66, 77, 148, 244, 274 |
| abstract_inverted_index.knowledge, | 56, 114, 209, 269 |
| abstract_inverted_index.obligation | 35 |
| abstract_inverted_index.physician, | 159 |
| abstract_inverted_index.profession | 152 |
| abstract_inverted_index.providers. | 67 |
| abstract_inverted_index.reporting. | 135 |
| abstract_inverted_index.statistics | 137 |
| abstract_inverted_index.translated | 52, 104, 258 |
| abstract_inverted_index.Background: | 0 |
| abstract_inverted_index.Conclusion: | 252 |
| abstract_inverted_index.Descriptive | 136 |
| abstract_inverted_index.Reliability | 140 |
| abstract_inverted_index.activities, | 26 |
| abstract_inverted_index.consistency | 196 |
| abstract_inverted_index.demographic | 83 |
| abstract_inverted_index.medications | 12 |
| abstract_inverted_index.reliability | 47 |
| abstract_inverted_index.specialists | 220 |
| abstract_inverted_index.(pharmacist, | 158 |
| abstract_inverted_index.Face-content | 214 |
| abstract_inverted_index.contributors | 23 |
| abstract_inverted_index.observational | 70 |
| abstract_inverted_index.questionnaire | 61, 106, 261 |
| abstract_inverted_index.significantly | 241 |
| abstract_inverted_index. Results: | 146 |
| abstract_inverted_index.questionnaire. | 226 |
| abstract_inverted_index.respectively). | 213 |
| abstract_inverted_index.cross-sectional | 71 |
| abstract_inverted_index.Cronbach’s | 144 |
| abstract_inverted_index.(Cronbach’s | 202 |
| abstract_inverted_index.Pharmacovigilance | 1 |
| abstract_inverted_index.pharmacovigilance | 25, 64, 250, 260 |
| abstract_inverted_index.practice. The | 39 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 91 |
| countries_distinct_count | 0 |
| institutions_distinct_count | 4 |
| citation_normalized_percentile.value | 0.82872751 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |